Wegovy Injection: Weight Loss Effect & Side effects
From My Diabetes Doc · 00:04:20
Show by Dr. Jonas Leibowitz
In this episode, I discuss the Wegovy injection, a GLP-1 medication for weight loss, which is part of the new Medicare Bridge program that started on July 1, 2026. In the first part of this episode, I discuss the weight-loss effects you can expect from this medication, and in the second part, I discuss the side effects associated with taking the Wegovy injection.The weight loss data is based on the 2.4 mg and 7.2 mg doses, with expected losses of 16% and 19% body weight, respectively, over a year. Side effects, primarily gastrointestinal, include nausea, vomiting, and dyspepsia. It's crucial to monitor these effects and gradually increase doses. Other safety concerns should be discussed with a doctor. I emphasize the importance of open communication with healthcare providers to ensure comfort and safety.This episode is for educational purposes only and is not a substitute for personalized medical advice. Talk with your healthcare provider before starting, stopping, or changing any medication.
More episodes of My Diabetes Doc
More episodes
- GLP-1 Medications and Thyroid Cancer: Should You Get Extra Tests or Change Your Treatment?
- GLP-1 Medications and Thyroid Cancer: What You Should Know
- What Happens If You Miss Multiple GLP-1 Doses?
- I have been diagnosed with diabetes, now what?
- I just found out I have type 2 diabetes, and I have symptoms
- Do You Qualify for Medicare's New GLP-1 Weight Loss Program?
- Introducing the Wegovy Injection & Explaining dosing. Covered under the Medicare GLP-1 Bridge Program
- Wegovy Injection: Summary of what to expect - Medicare GLP-1 Bridge Program
- Zepbound Explained: How It Works, How It’s Dosed & What Patients Should Know
- Medicare GLP-1 Bridge Program: Issues with Qualifying for the Program
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.